Laden...

Inovative food supplement for weight loss and reduction of the risks associated with overweight

In the world of probiotic bacterial strains and their beneficial effects on the human organism, there is a groundbreaking discovery from Kenya.

From a unique fermented product from millet, called Kimere, strains were isolated having a potential for weight loss and reduction of the risks associated with overweight.

The strains showed anti-inflammatory effect in in vitro studies which permits targeting these metabolic disorders, since they are driven by a low grade inflammation.

Clinical trials will follow.

Origin of the strains

A so far undescribed African fermented food, Kimere, was selected for isolation of potential probiotic lactobacilli (Njeru et al., 2009).

Kimere, a spontaneously fermented pearl millet dough common among the Mbeere community of Kenya, East Africa, is fermented for 18-24 hours and is consumed in its active fermenting state.

Kimere is similar in composition to the common East African porridge called Uji (Mbugua, 1984; Masha et al., 1998), however, it is thicker in texture and consistency.

In contrast to Uji, Kimere is consumed in an active fermenting state and hence contains living micro-organisms, while Uji is consumed immediately after boiling hence contains no live fermenting microorganisms (Njeru et al., 2009).

Isolation and characterization of microorganisms involved in fermentation of cereal products in East Africa still remain a rather unexplored area: a few scientific findings on fermenting microorganisms in various cereal foods and milk have been reported (Mbugua, 1984; Wangoh et al., 1992; Masha et al., 1998; Mugula et al., 2003; Muyanja et al., 2003; Mathara et al., 2004; Lore et al., 2005). In all of these studies, Lactobacillus fermentum and Lactobacillus plantarum seemed to be the dominant organisms.

People behind Slimbiotics

Helmut Essl

CEO, Founder and Partner

Helmut Essl

CEO, Founder and Partner
  • Over 10 years at HSO Health Care (Astarte for women’s health is „Probiotic Product of the Year 2019“, NIA Awards USA and Europe and Finalist in Asia)
  • Previously held roles in marketing of medical goods, assemblies and hospital equipment, and the distribution of pharmaceutical products and food supplements.
  • invested in several companies, start ups and real estates

essl@slimbiotics.com

Alex Schütz

Founder and Partner

Alex Schütz

Founder and Partner
  • Founder and board member of C-QUADRAT Investment, one of Europes largest and most successful fund-of-funds
  • Supervisory board member of Deutsche Bank since 2017
  • Over 5 years shareholder at HSO Health Care

schuetz@slimbiotics.com

Christian Angermayer

Partner

Christian Angermayer

Partner
Owner of Apeiron Investment Group, his family office and merchant banking business, which focuses in Germany and Africa on Financial Services (especially Fintech), Internet and Technology (from e-commerce to deep tech), Life Sciences, Media, Real Estate and Natural Resources

Jürgen Schrezenmeir

Scientific and Medical Advisor

Jürgen Schrezenmeir

Scientific and Medical Advisor
  • Professor of Internal Medicine at the Johannes-Gutenberg University Mainz
  • Former director of the Institute of Physiology and Biochemistry of Nutrition at the Max Rubner Institute, Kiel and Karlsruhe, respectively
  • Worked as scientific advisor for several companies in the pharmaceutical industry including Chr. Hansen, Danone, Humana and Campina and since 5 years for HSO Health Care

Contact

Slimbiotics GmbH
TUCHLAUBEN 18
1010 VIENNA
AUSTRIA

+43 1 2350780
office@slimbiotics.com